Advertisement

Topics

Australian firm raises funds for Phase III trial in rare neurological disorder

11:57 EDT 1 Aug 2017 | thePharmaLetter

Australian biopharmaceutical company Neuren Pharmaceuticals has landed a A$10 million ($8 million) investment…

Original Article: Australian firm raises funds for Phase III trial in rare neurological disorder

NEXT ARTICLE

More From BioPortfolio on "Australian firm raises funds for Phase III trial in rare neurological disorder"

Quick Search
Advertisement